4DMedical Ltd
ASX:4DX
4DMedical Ltd
ASX:4DX
Price:
6.8
AUD
8.11%
Market Closed
Market Cap:
AU$3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
4DMedical Ltd
ASX:4DX
|
AU |
|
B
|
Banco Bradesco SA
SWB:BREC
|
BR |
|
R
|
Rich Goldman Holdings Ltd
F:MRU3
|
HK |
|
Atossa Therapeutics Inc
NASDAQ:ATOS
|
US |
|
H
|
Helium Evolution Inc
XTSX:HEVI
|
CA |
|
HL Holdings Corp
KRX:060980
|
KR |
|
A
|
Amprius Technologies Operating Inc
NYSE:AMPX
|
US |
|
Burford Capital Ltd
NYSE:BUR
|
GG |
|
G
|
Geely Automobile Holdings Ltd
OTC:GELYF
|
HK |
|
Rover Metals Corp
F:4XO0
|
CA |
|
Malaysia Smelting Corporation Bhd
SGX:NPW
|
MY |
|
A
|
Agora SA
WSE:AGO
|
PL |
|
Mighty Kingdom Ltd
ASX:MKL
|
AU |
|
I
|
Invictus Energy Ltd
OTC:IVCTF
|
AU |
|
Bouvet ASA
OSE:BOUV
|
NO |
|
Nix Inc
TSE:4243
|
JP |
|
P
|
Patagonia Lithium Ltd
ASX:PL3
|
AU |
|
Orica Ltd
ASX:ORI
|
AU |
|
Double Bond Chemical Ind Co Ltd
TWSE:4764
|
TW |
|
Generative AI Solutions Corp
OTC:AICOF
|
CA |
Cash Flow Statement
Cash Flow Statement
4DMedical Ltd
4DMedical Ltd
Currency: AUD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Stock-Based Compensation |
3
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
(0)
|
1
|
7
|
|
| Cash Taxes Paid |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(3)
|
(5)
|
(2)
|
(7)
|
(4)
|
10
|
(4)
|
2
|
5
|
(3)
|
(2)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(15)
-93%
|
(15)
+2%
|
(23)
-59%
|
(25)
-10%
|
(13)
+50%
|
(23)
-79%
|
(8)
+64%
|
9
N/A
|
(4)
N/A
|
1
N/A
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(2)
|
(2)
|
0
|
1
|
(0)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(39)
|
0
|
39
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-24%
|
(1)
+40%
|
(3)
-390%
|
(4)
-23%
|
(2)
+46%
|
(2)
+15%
|
(38)
-2 281%
|
1
N/A
|
38
+4 899%
|
0
-100%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
1
|
48
|
94
|
46
|
0
|
0
|
45
|
(10)
|
(44)
|
(20)
|
54
|
|
| Net Issuance of Debt |
14
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
0
|
10
|
|
| Other |
(1)
|
(5)
|
(6)
|
(2)
|
0
|
1
|
(1)
|
(1)
|
1
|
1
|
(1)
|
|
| Cash from Financing Activities |
14
N/A
|
44
+217%
|
88
+101%
|
43
-51%
|
(1)
N/A
|
0
N/A
|
43
+43 456%
|
(11)
N/A
|
(42)
-293%
|
(20)
+54%
|
63
N/A
|
|
| Change in Cash | ||||||||||||
| Net Change in Cash |
5
N/A
|
28
+422%
|
72
+160%
|
17
-76%
|
(30)
N/A
|
(14)
+51%
|
18
N/A
|
(57)
N/A
|
(33)
+42%
|
15
N/A
|
65
+323%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(9)
N/A
|
(16)
-79%
|
(15)
+2%
|
(26)
-70%
|
(29)
-10%
|
(15)
+49%
|
(24)
-67%
|
(8)
+68%
|
9
N/A
|
(4)
N/A
|
1
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
